Napo Pharmaceuticals, Inc. Appoints Chief Operating Officer

SOUTH SAN FRANCISCO, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Napo Pharmaceuticals, Inc., (LSE: NAPL - News), which focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace in collaboration with local partners, is pleased to announce today that James Nash, age 56, has joined the Company as its Chief Operating Officer (COO). Mr. Nash has almost 30 years of experience with pharmaceutical and biotechnology companies including Chiron Corporation, Millenium Pharmaceuticals and Monsanto/Searle. Most recently, Mr. Nash worked at Watson Pharmaceuticals as Executive Vice President, Technical Operations where he was responsible for manufacturing, quality and sourcing, managing seven manufacturing locations worldwide.

Back to news